JP2008502651A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008502651A5 JP2008502651A5 JP2007515944A JP2007515944A JP2008502651A5 JP 2008502651 A5 JP2008502651 A5 JP 2008502651A5 JP 2007515944 A JP2007515944 A JP 2007515944A JP 2007515944 A JP2007515944 A JP 2007515944A JP 2008502651 A5 JP2008502651 A5 JP 2008502651A5
- Authority
- JP
- Japan
- Prior art keywords
- tetramethyl
- piperidine
- disorder
- phenoxy
- piperidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 125000000217 alkyl group Chemical group 0.000 claims 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 9
- 208000002193 Pain Diseases 0.000 claims 7
- 208000035475 disorder Diseases 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 206010012289 Dementia Diseases 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 206010034912 Phobia Diseases 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 125000001475 halogen functional group Chemical group 0.000 claims 4
- 208000019906 panic disease Diseases 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 208000030814 Eating disease Diseases 0.000 claims 3
- 208000019454 Feeding and Eating disease Diseases 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 235000014632 disordered eating Nutrition 0.000 claims 3
- 208000019899 phobic disease Diseases 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 208000011580 syndromic disease Diseases 0.000 claims 3
- -1 trifluoromethoxy, cyano, hydroxy, amino Chemical group 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- 208000007848 Alcoholism Diseases 0.000 claims 2
- 208000019901 Anxiety disease Diseases 0.000 claims 2
- 206010013654 Drug abuse Diseases 0.000 claims 2
- 208000010228 Erectile Dysfunction Diseases 0.000 claims 2
- 208000026139 Memory disease Diseases 0.000 claims 2
- 208000019022 Mood disease Diseases 0.000 claims 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- 206010043269 Tension headache Diseases 0.000 claims 2
- 208000008548 Tension-Type Headache Diseases 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 201000001881 impotence Diseases 0.000 claims 2
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 201000000980 schizophrenia Diseases 0.000 claims 2
- 208000011117 substance-related disease Diseases 0.000 claims 2
- RKMGAJGJIURJSJ-UHFFFAOYSA-N 2,2,6,6-Tetramethylpiperidine Substances CC1(C)CCCC(C)(C)N1 RKMGAJGJIURJSJ-UHFFFAOYSA-N 0.000 claims 1
- LCULDGORJZRIBF-UHFFFAOYSA-N 2,2,6,6-tetramethyl-4-(2,3,4-trichlorophenoxy)piperidine Chemical compound C1C(C)(C)NC(C)(C)CC1OC1=CC=C(Cl)C(Cl)=C1Cl LCULDGORJZRIBF-UHFFFAOYSA-N 0.000 claims 1
- MCTGZWHLAUFQMK-UHFFFAOYSA-N 2,2,6,6-tetramethyl-4-(2,4,5-trichlorophenoxy)piperidine Chemical compound C1C(C)(C)NC(C)(C)CC1OC1=CC(Cl)=C(Cl)C=C1Cl MCTGZWHLAUFQMK-UHFFFAOYSA-N 0.000 claims 1
- IURBEPNJIZNFTI-UHFFFAOYSA-N 2,2,6,6-tetramethyl-4-[4-(trifluoromethyl)phenoxy]piperidine Chemical compound C1C(C)(C)NC(C)(C)CC1OC1=CC=C(C(F)(F)F)C=C1 IURBEPNJIZNFTI-UHFFFAOYSA-N 0.000 claims 1
- OOUMMYJVOJNKMT-UHFFFAOYSA-N 2,2,6,6-tetramethyl-4-naphthalen-1-yloxypiperidine Chemical compound C1C(C)(C)NC(C)(C)CC1OC1=CC=CC2=CC=CC=C12 OOUMMYJVOJNKMT-UHFFFAOYSA-N 0.000 claims 1
- RLXOJODVMIWGIG-UHFFFAOYSA-N 2,2,6,6-tetramethyl-n-(2-naphthalen-1-yloxyphenyl)piperidin-4-amine Chemical compound C1C(C)(C)NC(C)(C)CC1NC1=CC=CC=C1OC1=CC=CC2=CC=CC=C12 RLXOJODVMIWGIG-UHFFFAOYSA-N 0.000 claims 1
- NHCJIOXLACYZGF-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenoxy)-2,2,6,6-tetramethylpiperidin-1-yl]acetonitrile Chemical compound C1C(C)(C)N(CC#N)C(C)(C)CC1OC1=CC=C(Cl)C(Cl)=C1 NHCJIOXLACYZGF-UHFFFAOYSA-N 0.000 claims 1
- ZSMSGPANWYJSDF-UHFFFAOYSA-N 4-(2,2,6,6-tetramethylpiperidin-4-yl)oxyphenol Chemical compound C1C(C)(C)NC(C)(C)CC1OC1=CC=C(O)C=C1 ZSMSGPANWYJSDF-UHFFFAOYSA-N 0.000 claims 1
- QYKMXNVTTLDZRT-UHFFFAOYSA-N 4-(2,4-dichlorophenoxy)-2,2,6,6-tetramethylpiperidine Chemical compound C1C(C)(C)NC(C)(C)CC1OC1=CC=C(Cl)C=C1Cl QYKMXNVTTLDZRT-UHFFFAOYSA-N 0.000 claims 1
- RZKSXFJQJRINNE-UHFFFAOYSA-N 4-(2,5-dichlorophenoxy)-2,2,6,6-tetramethylpiperidine Chemical compound C1C(C)(C)NC(C)(C)CC1OC1=CC(Cl)=CC=C1Cl RZKSXFJQJRINNE-UHFFFAOYSA-N 0.000 claims 1
- QUIHPAAKYUAPST-UHFFFAOYSA-N 4-(2-chloro-5-fluorophenoxy)-2,2,6,6-tetramethylpiperidine Chemical compound C1C(C)(C)NC(C)(C)CC1OC1=CC(F)=CC=C1Cl QUIHPAAKYUAPST-UHFFFAOYSA-N 0.000 claims 1
- IHNYEZOKKMPVJC-UHFFFAOYSA-N 4-(3,4-dichlorophenoxy)-1,2,2,6,6-pentamethylpiperidine Chemical compound C1C(C)(C)N(C)C(C)(C)CC1OC1=CC=C(Cl)C(Cl)=C1 IHNYEZOKKMPVJC-UHFFFAOYSA-N 0.000 claims 1
- WMBGSNGCTXWNAL-UHFFFAOYSA-N 4-(3,4-dichlorophenoxy)-2,2,6,6-tetramethylpiperidine Chemical compound C1C(C)(C)NC(C)(C)CC1OC1=CC=C(Cl)C(Cl)=C1 WMBGSNGCTXWNAL-UHFFFAOYSA-N 0.000 claims 1
- WJPZZJGQMUEKDD-UHFFFAOYSA-N 4-(3-bromo-4-chlorophenoxy)-2,2,6,6-tetramethylpiperidine Chemical compound C1C(C)(C)NC(C)(C)CC1OC1=CC=C(Cl)C(Br)=C1 WJPZZJGQMUEKDD-UHFFFAOYSA-N 0.000 claims 1
- MWSDEOAIPFHYFO-UHFFFAOYSA-N 4-(3-chloro-4-fluorophenoxy)-1,2,2,6,6-pentamethylpiperidine Chemical compound C1C(C)(C)N(C)C(C)(C)CC1OC1=CC=C(F)C(Cl)=C1 MWSDEOAIPFHYFO-UHFFFAOYSA-N 0.000 claims 1
- IQVZVIOUZNOTGR-UHFFFAOYSA-N 4-(3-chloro-4-fluorophenoxy)-2,2,6,6-tetramethylpiperidine Chemical compound C1C(C)(C)NC(C)(C)CC1OC1=CC=C(F)C(Cl)=C1 IQVZVIOUZNOTGR-UHFFFAOYSA-N 0.000 claims 1
- GEEUVJGRVRIWDT-UHFFFAOYSA-N 4-(4-bromo-3-chlorophenoxy)-2,2,6,6-tetramethylpiperidine Chemical compound C1C(C)(C)NC(C)(C)CC1OC1=CC=C(Br)C(Cl)=C1 GEEUVJGRVRIWDT-UHFFFAOYSA-N 0.000 claims 1
- BLFCOKICYVRNOU-UHFFFAOYSA-N 4-(4-chloro-3-fluorophenoxy)-1,2,2,6,6-pentamethylpiperidine Chemical compound C1C(C)(C)N(C)C(C)(C)CC1OC1=CC=C(Cl)C(F)=C1 BLFCOKICYVRNOU-UHFFFAOYSA-N 0.000 claims 1
- PXQGBETVFHGWJF-UHFFFAOYSA-N 4-(4-chlorophenoxy)-2,2,6,6-tetramethylpiperidine Chemical compound C1C(C)(C)NC(C)(C)CC1OC1=CC=C(Cl)C=C1 PXQGBETVFHGWJF-UHFFFAOYSA-N 0.000 claims 1
- JAUBPQRKTICTCA-UHFFFAOYSA-N 4-(4-methoxyphenoxy)-2,2,6,6-tetramethylpiperidine Chemical compound C1=CC(OC)=CC=C1OC1CC(C)(C)NC(C)(C)C1 JAUBPQRKTICTCA-UHFFFAOYSA-N 0.000 claims 1
- ROWKXROIWYNFFF-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)phenoxy]-1,2,2,6,6-pentamethylpiperidine Chemical compound C1C(C)(C)N(C)C(C)(C)CC1OC1=CC=C(Cl)C(C(F)(F)F)=C1 ROWKXROIWYNFFF-UHFFFAOYSA-N 0.000 claims 1
- GGTIYJFYUYCJQS-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)phenoxy]-2,2,6,6-tetramethylpiperidine Chemical compound C1C(C)(C)NC(C)(C)CC1OC1=CC=C(Cl)C(C(F)(F)F)=C1 GGTIYJFYUYCJQS-UHFFFAOYSA-N 0.000 claims 1
- 208000030507 AIDS Diseases 0.000 claims 1
- 201000004384 Alopecia Diseases 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000000044 Amnesia Diseases 0.000 claims 1
- 206010003591 Ataxia Diseases 0.000 claims 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 1
- 206010003805 Autism Diseases 0.000 claims 1
- 208000020706 Autistic disease Diseases 0.000 claims 1
- 208000008035 Back Pain Diseases 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 208000032841 Bulimia Diseases 0.000 claims 1
- 206010006550 Bulimia nervosa Diseases 0.000 claims 1
- 206010058019 Cancer Pain Diseases 0.000 claims 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims 1
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- 208000022497 Cocaine-Related disease Diseases 0.000 claims 1
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 claims 1
- 208000027534 Emotional disease Diseases 0.000 claims 1
- 208000026097 Factitious disease Diseases 0.000 claims 1
- 208000001640 Fibromyalgia Diseases 0.000 claims 1
- 208000011688 Generalised anxiety disease Diseases 0.000 claims 1
- 206010065390 Inflammatory pain Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 208000000112 Myalgia Diseases 0.000 claims 1
- 208000028389 Nerve injury Diseases 0.000 claims 1
- 206010029216 Nervousness Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000027089 Parkinsonian disease Diseases 0.000 claims 1
- 206010034010 Parkinsonism Diseases 0.000 claims 1
- 208000004983 Phantom Limb Diseases 0.000 claims 1
- 206010056238 Phantom pain Diseases 0.000 claims 1
- 208000008348 Post-Concussion Syndrome Diseases 0.000 claims 1
- 208000004550 Postoperative Pain Diseases 0.000 claims 1
- 206010036618 Premenstrual syndrome Diseases 0.000 claims 1
- 206010052276 Pseudodementia Diseases 0.000 claims 1
- 208000005793 Restless legs syndrome Diseases 0.000 claims 1
- 201000001880 Sexual dysfunction Diseases 0.000 claims 1
- 206010041250 Social phobia Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000011962 Substance-induced mood disease Diseases 0.000 claims 1
- 231100000395 Substance-induced mood disorder Toxicity 0.000 claims 1
- 206010043903 Tobacco abuse Diseases 0.000 claims 1
- 208000000323 Tourette Syndrome Diseases 0.000 claims 1
- 208000031674 Traumatic Acute Stress disease Diseases 0.000 claims 1
- 206010046543 Urinary incontinence Diseases 0.000 claims 1
- 208000026345 acute stress disease Diseases 0.000 claims 1
- 201000007930 alcohol dependence Diseases 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims 1
- 208000025748 atypical depressive disease Diseases 0.000 claims 1
- 208000029028 brain injury Diseases 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 201000001272 cocaine abuse Diseases 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 206010013663 drug dependence Diseases 0.000 claims 1
- 210000001097 facial muscle Anatomy 0.000 claims 1
- 208000029364 generalized anxiety disease Diseases 0.000 claims 1
- 210000002816 gill Anatomy 0.000 claims 1
- 208000024963 hair loss Diseases 0.000 claims 1
- 230000003676 hair loss Effects 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 206010020765 hypersomnia Diseases 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 230000000938 luteal effect Effects 0.000 claims 1
- 238000012423 maintenance Methods 0.000 claims 1
- 208000024714 major depressive disease Diseases 0.000 claims 1
- 230000006984 memory degeneration Effects 0.000 claims 1
- 230000007074 memory dysfunction Effects 0.000 claims 1
- 206010027175 memory impairment Diseases 0.000 claims 1
- 208000023060 memory loss Diseases 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 208000013465 muscle pain Diseases 0.000 claims 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims 1
- QOVTZYVVCOIIBT-UHFFFAOYSA-N n-(2,3-dimethoxyphenyl)-2,2,6,6-tetramethylpiperidin-4-amine Chemical compound COC1=CC=CC(NC2CC(C)(C)NC(C)(C)C2)=C1OC QOVTZYVVCOIIBT-UHFFFAOYSA-N 0.000 claims 1
- NLCWQNJAKKLPFS-UHFFFAOYSA-N n-(2,4-dichlorophenyl)-2,2,6,6-tetramethylpiperidin-4-amine Chemical compound C1C(C)(C)NC(C)(C)CC1NC1=CC=C(Cl)C=C1Cl NLCWQNJAKKLPFS-UHFFFAOYSA-N 0.000 claims 1
- ZCSKMPUCIIYYFX-UHFFFAOYSA-N n-(2,5-dichlorophenyl)-2,2,6,6-tetramethylpiperidin-4-amine Chemical compound C1C(C)(C)NC(C)(C)CC1NC1=CC(Cl)=CC=C1Cl ZCSKMPUCIIYYFX-UHFFFAOYSA-N 0.000 claims 1
- BKMQASILXPDTHY-UHFFFAOYSA-N n-(2-bromo-4-chloro-5-methoxyphenyl)-2,2,6,6-tetramethylpiperidin-4-amine Chemical compound C1=C(Cl)C(OC)=CC(NC2CC(C)(C)NC(C)(C)C2)=C1Br BKMQASILXPDTHY-UHFFFAOYSA-N 0.000 claims 1
- JZERIWHTWQKHKP-UHFFFAOYSA-N n-(2-chloro-5-fluorophenyl)-2,2,6,6-tetramethylpiperidin-4-amine Chemical compound C1C(C)(C)NC(C)(C)CC1NC1=CC(F)=CC=C1Cl JZERIWHTWQKHKP-UHFFFAOYSA-N 0.000 claims 1
- LMSSARPMNOMFSL-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-2,2,6,6-tetramethylpiperidin-4-amine Chemical compound C1C(C)(C)NC(C)(C)CC1NC1=CC=C(Cl)C(Cl)=C1 LMSSARPMNOMFSL-UHFFFAOYSA-N 0.000 claims 1
- GEMHCWUYVPXNGX-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-n,1,2,2,6,6-hexamethylpiperidin-4-amine Chemical compound C=1C=C(Cl)C(Cl)=CC=1N(C)C1CC(C)(C)N(C)C(C)(C)C1 GEMHCWUYVPXNGX-UHFFFAOYSA-N 0.000 claims 1
- SUEMQYXPDPITQZ-UHFFFAOYSA-N n-(3-chloro-4-fluorophenyl)-2,2,6,6-tetramethylpiperidin-4-amine Chemical compound C1C(C)(C)NC(C)(C)CC1NC1=CC=C(F)C(Cl)=C1 SUEMQYXPDPITQZ-UHFFFAOYSA-N 0.000 claims 1
- MHKBXZAAAXPRHO-UHFFFAOYSA-N n-(4-chloro-2-fluorophenyl)-2,2,6,6-tetramethylpiperidin-4-amine Chemical compound C1C(C)(C)NC(C)(C)CC1NC1=CC=C(Cl)C=C1F MHKBXZAAAXPRHO-UHFFFAOYSA-N 0.000 claims 1
- FOBVFFRIICNIMJ-UHFFFAOYSA-N n-(4-chloro-3-methoxyphenyl)-2,2,6,6-tetramethylpiperidin-4-amine Chemical compound C1=C(Cl)C(OC)=CC(NC2CC(C)(C)NC(C)(C)C2)=C1 FOBVFFRIICNIMJ-UHFFFAOYSA-N 0.000 claims 1
- AQWHDVGMCJDQIB-UHFFFAOYSA-N n-[4-chloro-3-(trifluoromethyl)phenyl]-2,2,6,6-tetramethylpiperidin-4-amine Chemical compound C1C(C)(C)NC(C)(C)CC1NC1=CC=C(Cl)C(C(F)(F)F)=C1 AQWHDVGMCJDQIB-UHFFFAOYSA-N 0.000 claims 1
- 210000005036 nerve Anatomy 0.000 claims 1
- 230000008764 nerve damage Effects 0.000 claims 1
- 208000004296 neuralgia Diseases 0.000 claims 1
- 208000021722 neuropathic pain Diseases 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 239000002858 neurotransmitter agent Substances 0.000 claims 1
- 230000000422 nocturnal effect Effects 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- 150000003053 piperidines Chemical class 0.000 claims 1
- 208000028173 post-traumatic stress disease Diseases 0.000 claims 1
- 201000000484 premenstrual tension Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 231100000872 sexual dysfunction Toxicity 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 208000020685 sleep-wake disease Diseases 0.000 claims 1
- 201000001716 specific phobia Diseases 0.000 claims 1
- 230000035882 stress Effects 0.000 claims 1
- 201000009032 substance abuse Diseases 0.000 claims 1
- 230000002889 sympathetic effect Effects 0.000 claims 1
- 208000004371 toothache Diseases 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
- 206010044652 trigeminal neuralgia Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200400961 | 2004-06-18 | ||
| US58135904P | 2004-06-22 | 2004-06-22 | |
| PCT/EP2005/052731 WO2005123679A2 (en) | 2004-06-18 | 2005-06-14 | Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008502651A JP2008502651A (ja) | 2008-01-31 |
| JP2008502651A5 true JP2008502651A5 (enExample) | 2008-06-19 |
Family
ID=37311739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007515944A Abandoned JP2008502651A (ja) | 2004-06-18 | 2005-06-14 | モノアミン神経伝達物質再取込み阻害剤としての、新規アルキル置換ピペリジン誘導体及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US7547788B2 (enExample) |
| EP (1) | EP1761493A2 (enExample) |
| JP (1) | JP2008502651A (enExample) |
| CN (1) | CN1960974A (enExample) |
| AR (1) | AR050341A1 (enExample) |
| CA (1) | CA2570075A1 (enExample) |
| MX (1) | MXPA06013917A (enExample) |
| TW (1) | TW200604173A (enExample) |
| WO (1) | WO2005123679A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2570075A1 (en) * | 2004-06-18 | 2005-12-29 | Neurosearch A/S | Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| EP1896415A1 (en) * | 2005-06-08 | 2008-03-12 | NeuroSearch A/S | Novel n-phenyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| US20110046179A1 (en) * | 2006-08-30 | 2011-02-24 | Eriksen Birgitte L | Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| MX2010009581A (es) * | 2008-03-05 | 2010-09-30 | Neurosearch As | Derivados novedosos de 4-bencidriloxi-tetraalquil-piperidina y su uso como inhibidores de reabsorcion del neurotransmisor de monoamina. |
| US8546576B2 (en) * | 2008-06-06 | 2013-10-01 | Sk Biopharmaceuticals Co., Ltd. | 3 or 4-substituted piperidine compounds |
| US20170204060A1 (en) * | 2014-05-21 | 2017-07-20 | Solvay Specialty Polymers Usa, Llc | Piperidine-based stabilizers and polymers end-capped with the same |
| EP3145911B1 (en) * | 2014-05-21 | 2020-07-08 | Solvay Specialty Polymers USA, L.L.C. | Stabilizer compounds |
| MX374426B (es) | 2015-01-22 | 2025-03-06 | Evonik Operations Gmbh | Sintesis de compuestos de triacetonadiamina mediante procedimiento de aminacion reductora de triacetonadiamina y derivados de los mismos. |
| MX2016000701A (es) | 2015-01-22 | 2016-11-24 | Evonik Degussa Gmbh | Proceso para preparar un compuesto de triacetonamina n-metil sustituida. |
| DE102016212378A1 (de) | 2016-07-07 | 2018-01-11 | Evonik Degussa Gmbh | Synthese von Triacetondiaminverbindungen durch reduktive Aminierung ausgehend von Triacetondiamin und dessen Derivaten |
| DE102016212379A1 (de) | 2016-07-07 | 2018-01-11 | Evonik Degussa Gmbh | Verfahren zur Herstellung einer N-methylsubstituierten Triacetonaminverbindung |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3684765A (en) * | 1970-01-08 | 1972-08-15 | Sankyo Co | Stabilization of synthetic polymers |
| GB1411782A (en) | 1972-02-24 | 1975-10-29 | Wyeth John & Brother Ltd | Piperidine derivatives |
| US3907813A (en) * | 1973-09-11 | 1975-09-23 | Janssen Pharmaceutica Nv | Stereoisomeric forms of 4-anilino-3-methyl piperidines |
| US3923992A (en) * | 1974-05-23 | 1975-12-02 | Univ Mississippi | Analgetic composition and method of use |
| FR2361880A1 (fr) * | 1976-04-29 | 1978-03-17 | Science Union & Cie | Nouvelles 4-amino piperidines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant |
| DE3218645A1 (de) * | 1982-05-18 | 1983-11-24 | Hoechst Ag, 6230 Frankfurt | Fluoranverbindungen, verfahren zu ihrer herstellung und ihre verwendung als farbbilder in kopiersystemen |
| JPS63206757A (ja) | 1987-02-23 | 1988-08-26 | Mitsubishi Paper Mills Ltd | 電子写真感光体 |
| US5019583A (en) | 1989-02-15 | 1991-05-28 | Glaxo Inc. | N-phenyl-N-(4-piperidinyl)amides useful as analgesics |
| US4939161A (en) * | 1989-05-12 | 1990-07-03 | Boc, Inc. | Analgesic N-aryl-N-[1-substituted-3,5-dimethyl-4-piperidinyl]amides |
| WO1991003511A1 (en) | 1989-09-09 | 1991-03-21 | Sandoz Ltd | Synthetic polyamides and their salts |
| ZA971525B (en) | 1996-02-22 | 1997-10-21 | Neurosearch As | Tropane derivatives, their preparation and use. |
| JPH11348418A (ja) | 1998-04-08 | 1999-12-21 | Seiko Epson Corp | 記録媒体および記録液 |
| US6303627B1 (en) * | 1998-06-19 | 2001-10-16 | Eli Lilly And Company | Inhibitors of serotonin reuptake |
| WO2002089803A1 (fr) * | 2001-05-07 | 2002-11-14 | Sankyo Company, Limited | Composition d'ionophorese |
| DE60331762D1 (de) | 2002-11-01 | 2010-04-29 | Neurosearch As | Neue piperidinderivate und deren verwendung als monoaminneurotransmitter-wiederaufnahmehemmer |
| CA2570075A1 (en) * | 2004-06-18 | 2005-12-29 | Neurosearch A/S | Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
-
2005
- 2005-06-14 CA CA002570075A patent/CA2570075A1/en not_active Abandoned
- 2005-06-14 MX MXPA06013917A patent/MXPA06013917A/es not_active Application Discontinuation
- 2005-06-14 US US11/579,060 patent/US7547788B2/en not_active Expired - Fee Related
- 2005-06-14 JP JP2007515944A patent/JP2008502651A/ja not_active Abandoned
- 2005-06-14 EP EP05761133A patent/EP1761493A2/en not_active Withdrawn
- 2005-06-14 WO PCT/EP2005/052731 patent/WO2005123679A2/en not_active Ceased
- 2005-06-14 CN CNA2005800172558A patent/CN1960974A/zh active Pending
- 2005-06-17 TW TW094120094A patent/TW200604173A/zh unknown
- 2005-06-17 AR ARP050102507A patent/AR050341A1/es unknown
-
2009
- 2009-05-07 US US12/437,233 patent/US7915419B2/en not_active Expired - Fee Related
-
2010
- 2010-12-16 US US12/970,274 patent/US20110086880A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010513392A5 (enExample) | ||
| RU98117314A (ru) | Тропановые производные, их получение и применение | |
| RU2655919C2 (ru) | Производные аминоциклобутана, способ их получения и их применение в качестве лекарственных средств | |
| JP5529150B2 (ja) | ４−［２−（２−フルオロフェノキシメチル）フェニル］ピペリジン化合物 | |
| UA105629C2 (uk) | Похідні арилсульфоніл піразолін карбоксамідину як антагоністи 5-нт6 | |
| RU2007106970A (ru) | Новые хромен-2-оновые производные и их применение в качестве ингибиторов обратного захвата моноаминовых нейромедиаторов | |
| NZ592563A (en) | 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands | |
| JP2009526816A5 (enExample) | ||
| Ma et al. | Practical synthesis, antidepressant, and anticonvulsant activity of 3‐phenyliminoindolin‐2‐one derivatives | |
| RU2006131454A (ru) | Новые производные мочевины и их медицинское применение | |
| JP2009537599A5 (enExample) | ||
| JP2008535860A5 (enExample) | ||
| JP2010513391A5 (enExample) | ||
| JP2006517568A5 (enExample) | ||
| JP2008502652A5 (enExample) | ||
| JP2008524161A5 (enExample) | ||
| JP2006507363A5 (enExample) | ||
| JP2009526023A5 (enExample) | ||
| JP2008502651A (ja) | モノアミン神経伝達物質再取込み阻害剤としての、新規アルキル置換ピペリジン誘導体及びその使用 | |
| JP2008502650A5 (enExample) | ||
| JP2008526923A5 (enExample) | ||
| RU2006140687A (ru) | Новые алкил-замещенные производные пиперазина и их применение в качестве ингибиторов обратного захвата моноаминовых нейротрансмиттеров | |
| JP2010501624A5 (enExample) | ||
| JP2008502653A5 (enExample) | ||
| JP2008546828A5 (enExample) |